Tuesday, September 28, 2021
wellness India Expo
Home Tags PATH

Tag: PATH

PHC Tech Challenge: A hunt for innovations to address primary healthcare...

The PHC Tech Challenge is launched in partnership with the Office of the Principal Scientific Adviser to the Government of India, PATH, Centre for Cellular and Molecular Platform, Social Alpha, Swasth, ACT, Stanford Byers Centre for Biodesign, and The Stanford Centre for Innovation in Global Health..................

GSK, PATH & Bharat Biotech sign product transfer agreement over malaria...

Bharat Biotech to produce antigen for world’s first vaccine against Plasmodium falciparum malaria following technology transfer, to help ensure long-term sustainable supply. Transfer builds on GSK commitments to donate up to 10 million vaccine doses.......................

The Rockefeller Foundation awards grants worth $5.5 million to scale up...

To support the expansion of Covid-19 testing and contact tracing across India, The Rockefeller Foundation announced two new grants to The Center for Cellular and Molecular Platforms and PATH.....................

Global workshop to develop IRS for Sabin Inactivated Polio vaccine held...

The two day global workshop aimed to discuss and finalize the candidate for International Reference Standard for Sabin Sabin Inactivated Polio vaccine is being organized by PATH with a grant supported by Gates Foundation on 11th and 12th July at Hyderabad...…………...

PATH & SD BIOSENSOR partner on diagnostic test critical for malaria...

The agreement supports development and availability of an affordable, high-quality enzyme deficiency test.................

Dr Satya Dash joins the Board of Venture Center

Having recently taken up the role of Director of Impact Lab at New Delhi based PATH India, Dr Satya Dash has now also joined the Board of Venture Center, Pune..............

HITLAB & Unitus Seed Fund announce winners of 2018 HITLAB World...

The 4th HITLAB Innovators Summit held on February 10 at the Indian Institute of Technology, Delhi featured speakers from leading organizations including Johnson & Johnson, Stryker, IBM, PATH, Terumo, and more............................

WHO grants prequalification to Bharat Biotech’s rotavirus vaccine, ROTAVAC

ROTAVAC has been under development since the year 2000 necessitating investments of around USD 200 million towards product development and dedicated manufacturing infrastructure. The WHO approval will help in making it accessible and affordable.......

Tata Trusts & PATH join hands for India’s first ‘Impact Lab...

Partnership will drive sustainable, high-impact solutions for low resource settings in India and beyond from ‘Lab to Market’.......

Serum Institute’s ROTASIIL shows great efficacy, included in national immunization program

The international nonprofit PATH partnered with Serum Institute of India to evaluate the vaccine which demonstrated significant efficacy against severe rotavirus gastroenteritis during its Phase 3 trials...........